Related Experiment Video
Updated: Jun 24, 2026

08:20
Superior Auto-Identification of Trypanosome Parasites by Using a Hybrid Deep-Learning Model
Published on: October 27, 2023
Amebiasis as a neglected tropical disease: Current knowledge gaps and future directions
Debbie-Ann Shirley1, Shasika Jayarathne2, Cirle A Warren3
1Department of Pediatrics, Division of Infectious Diseases, University of Florida College of Medicine, Gainesville, Florida, United States of America.
Plos Neglected Tropical Diseases
|June 22, 2026
Summary
Entamoeba histolytica causes amebiasis, a significant diarrheal and liver disease globally. Urgent investment is needed for better diagnostics, treatments, and vaccines for this neglected tropical disease.
Area of Science:
- Tropical medicine
- Infectious diseases
- Parasitology
Background:
- Entamoeba histolytica causes amebic colitis and liver abscesses, major causes of diarrheal disease and extraintestinal infections worldwide.
- Disease burden is high in resource-limited areas and clinically relevant in travelers and immunocompromised individuals.
- Current diagnostics are underutilized, treatments are limited to nitroimidazoles, and no vaccine is available.
Purpose of the Study:
- To highlight the persistent gaps in diagnostics, therapeutics, and prevention for amebiasis.
- To emphasize the need for reprioritizing amebiasis as a neglected tropical disease.
- To call for accelerated investment in control strategies.
Main Methods:
- Review of current understanding of Entamoeba histolytica epidemiology and pathogenesis.
- Analysis of limitations in molecular diagnostics, treatment options, and vaccine development.
- Assessment of the impact of immunosuppression on disease severity.
Main Results:
- Molecular diagnostics improve E. histolytica identification but face accessibility issues in endemic regions.
- Nitroimidazoles are the sole treatment for invasive disease, with limited alternatives for intolerance or resistance.
- No licensed vaccine exists, with minimal progress in development.
Conclusions:
- Significant gaps persist in amebiasis control, necessitating increased focus and investment.
- Reprioritizing amebiasis as a neglected tropical disease is crucial for global health.
- Accelerated development of novel diagnostics, therapeutics, and preventive strategies is urgently required.
Related Concept Videos
Amebiasis
Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
American Trypanosomiasis
Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Fungal Phylum Microsporidia
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Giardiasis
Giardiasis is a globally prevalent intestinal infection caused by the protozoan parasite Giardia duodenalis (also known as G. lamblia or G. intestinalis). This flagellated protozoan is the most frequently identified intestinal parasite in the United States and worldwide. Transmission primarily occurs via the fecal-oral route, with infection arising from ingestion of water or food contaminated with cysts. Individuals in low-resource settings, international travelers, outdoor enthusiasts, daycare...
Toxoplasmosis
Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...

